该HFSA高级心力衰竭和移植心脏病学奖学金共识会议共识会议
Mark H Drazner1, Amrut V Ambardekar2, Kathryn Berlacher3
1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Journal of cardiac failure
|October 8, 2023
概括
心脏病学实习生对高级心力衰竭/移植心脏病学 (AHFTC) 奖学金的兴趣正在下降. 通过专家采访和共识会议,制定了提高奖学金价值和解决这一趋势的策略.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭 奖学金 培训 培训
背景情况:
- 显而易见的是,心脏病学学员对高级心力衰竭/移植心脏病学 (AHFTC) 奖学金的兴趣在减少.
- 越来越少的申请人参加了这个专业的全国居民匹配计划.
研究的目的:
- 为了解决对AHFTC奖学金的兴趣日益减弱.
- 制定策略,以提高AHFTC培训的价值主张.
主要方法:
- 美国心力衰竭协会 (HFSA) 召开了一个AHFTC学术团队工作组.
- 44名专家利益相关者进行了虚拟采访.
- 一个AHFTC奖学金共识会议于2023年4月举行.
主要成果:
- 潜在的解决方案被分为五个主题:替代培训途径,监管和补偿,教育改进,管道开发和生活质量/心理健康.
- 对HFSA董事会提出了建议.
结论:
- 高金融管理局正在实施基于共识会议建议的战略计划.
- 本文更新了心力衰竭社区关于HFSA AHFTC奖学金工作组和共识会议的过程和概念.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure III: Clinical Manifestations
22
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
22


